Barriers removed for pharmacists to seek mental health treatment
Changes in Australian mandatory reporting laws will remove barriers to mental health treatment for health professionals.
Australian federal, state and territory health ministers at April’s...
PSA18 maps out the future of pharmacy
PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a...
Youth mental health in focus: young minds, meds and moods
Mental health conditions are a leading cause of disease burden for Australians aged 16–24 years, with nearly 40% experiencing a mental health disorder within a 12-month period.
PBS listings for cancer, Parkinson’s and motor neurone disease
Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS).
The...
PSA working to increase pharmacist remuneration
PSA has this week lodged two major submissions addressing pharmacist remuneration.
The first is our response to the Medicare Benefits Schedule Review Taskforce, where...
Spending on medicines rises even as dispensing drops
Australian prescription dispensing volume is lower, but spending on PBS medicines has increased in the past two years, according to the Australian Institute of...
